Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors

Orexin receptor antagonists represent attractive targets for the development of drugs for the treatment of insomnia. Both efficacy and safety are crucial in clinical settings and thorough investigations of pharmacokinetics and pharmacodynamics can predict contributing factors such as duration of act...

Descripción completa

Detalles Bibliográficos
Autores principales: Callander, Gabrielle E., Olorunda, Morenike, Monna, Dominique, Schuepbach, Edi, Langenegger, Daniel, Betschart, Claudia, Hintermann, Samuel, Behnke, Dirk, Cotesta, Simona, Fendt, Markus, Laue, Grit, Ofner, Silvio, Briard, Emmanuelle, Gee, Christine E., Jacobson, Laura H., Hoyer, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847553/
https://www.ncbi.nlm.nih.gov/pubmed/24376396
http://dx.doi.org/10.3389/fnins.2013.00230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847553/
https://www.ncbi.nlm.nih.gov/pubmed/24376396
http://dx.doi.org/10.3389/fnins.2013.00230

Ejemplares similares